Phosphate-binder therapy is associated with reduced mortality in men with non-dialysis-dependent CKD, a study found. The study, led by Csaba P. Kovesdy, MD, of Salem VA Medical Center in Salem, Va., ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Once hyperphosphatemia occurs, we like to ...

NASHVILLE—Data from a small study suggest that dialysis patients can achieve adequate phosphorus control if they switch to lanthanum carbonate after unsuccessful treatment with other phosphate binders ...

OLC received a Complete Response Letter from the FDA due to manufacturing deficiencies unrelated to the drug itself, prompting Unicycive to seek FDA guidance. OLC aims to reduce pill burden and ...